Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of action.

by Odile E Levy, Carolyn M Jodka, Shijun Steven Ren, Lala Mamedova, Abhinandini Sharma, Manoj Samant, Lawrence J D'Souza, Christopher J Soares, Diane R Yuskin, Li Jenny Jin, David G Parkes, Krystyna Tatarkiewicz, Soumitra S Ghosh
Published 2014-01-01